1Xiao-Ju Guan Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 200031,China,previously worked as a postdoc in Institute of Immunology,Third Military Medical University,Chongqing 400038,China Xiao-Jun Guan,Department of Science & Research,Second Military Medical University,Shanghai 200433,China Yu-Zhang Wu Zheng-Cai Jia Tong-Dong Shi Yan Tan,Institute of Immunology,Third Military Medical University,Chongqing 400038,China.Construction and characterization of an experimental ISCOMS-based hepatitis B polypeptide vaccine[J].World Journal of Gastroenterology,2002,8(2):294-297. 被引量：11
9[1]Morein B,Sundquist B,Hoglund S,et al.Iscom,a novel structure for antigenic presentation of membrane proteins from enveloped viruses[J].Nature,1984,308(5 958):457-460.
10[2]Takahashi H,Takeshita T,Morein B,et al.Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs[J].Nature,1990,344(6 269):873-875.
5Wen YM, Wu XH, Hu DC, et al. Hepatitis B vaccine and anti-HBs complex as approach for vaccine therapy. Lancet, 1995, 345: 1575-1576.
6Wen YM, Qu D, Zhou SH. Antigen-antibody complex as therapeutic vaccine for viral hepatitis B. Int Rev Immunol, 1999, 18: 251-258.
7Davis HL, Mancini M, Michel ML, et al. DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost. Vaccine, 1996, 14: 910-915.
8Kwissa M, Unsinger J, Schirmbeck R, et al. Polyvalent DNA vaccines with bidirectional promoters. J Mol Med, 2000, 78- 495-506.
9Pol S, Driss F, Michel ML, et al. Specific vaccine therapy in chronic hepatitis B infection. Lancet, 1994, 344: 342.
10Livingston BD, Alexander J, Crimi C, et al. Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans. J Immunol, 1999, 162: 3088-3095.
